iLeaf
For general mobile users and healthcare professionals seeking specific functional tools for time management, accessibility, and clinical calculations.
Snapshot
Who is iLeaf?
Providing accessible utility and productivity tools for mobile users. Focused on integrating system-level features into daily workflows.
Target audience
Portfolio
Free 4Last updated
iTextSpeaker - Text to speech
v7.7.5
4mo ago
Publisher DNA
What defines iLeaf?
Publisher DNA
Primary focus
Utility and productivity software
Scale
indie
Target audience
General mobile users and healthcare professionals seeking specific functional tools for time management, accessibility, and clinical calculations.
Signature Patterns
- โขDeep integration with native iOS features and Apple Watch.
- โขFocus on functional, single-purpose utilities rather than content-heavy apps.
- โขMixed monetization strategy ranging from free ad-supported tools to paid medical utilities.
- โขHigh variance in app maintenance, with a mix of frequently updated tools and long-dormant legacy projects.
Portfolio momentum
Released 13 updates across 6 apps in the last 6 months, indicating a recent surge in development activity despite a history of abandoned projects.
Portfolio
What does iLeaf ship?
Apps
Distributed across 10 markets, strongest in Europe.
Based on 2 of 6 apps with localized market data, more coverage rolling in as scans complete ยท last scanned .
Americas (3)
- United States2 / 2
- Brazil1 / 2
- Mexico1 / 2
Europe (5)
- France1 / 2
- Germany1 / 2
- Italy1 / 2
- Portugal1 / 2
- Spain1 / 2
Asia-Pacific (2)
- Japan2 / 2
- South Korea1 / 2
Core markets (2/2 apps)
Rivals
Who does iLeaf compete with?
The rivals identified
Nemeses(1)
DripRate targets the same healthcare professional audience as Drip Infusion by providing IV drip rate and volume calculations. It competes for price-sensitive users through an ad-supported free model.
Contenders(10)
Both apps target healthcare professionals and nursing students with IV drip rate calculation tools, creating direct competition for clinical utility and educational reference.
Both apps target clinicians performing intravenous therapy calculations, competing for the same professional user base at a similar low-cost price point.
Both applications target healthcare professionals performing IV gravity infusion calculations, competing directly for the same clinical utility use case.
Both apps target clinicians managing intravenous therapy, creating direct competition for the same professional user base.
Both apps target healthcare professionals requiring clinical calculation tools, creating direct competition for the same user's device storage and attention.
Both apps target healthcare professionals for intravenous therapy calculations, competing directly for clinical utility in high-stakes environments.
Both applications target healthcare professionals performing intravenous therapy calculations, creating direct competition for clinical utility in the same medical niche.
Both apps target healthcare professionals managing intravenous therapy, competing for clinical utility in medical settings.
Both apps target healthcare professionals managing intravenous therapy, with IV Medications Gahart providing administration calculators that overlap with the core functionality of Drip Infusion.
Both apps target healthcare professionals for intravenous therapy calculations, competing for the same clinical workflow utility space.
Same space(1)
This app targets the same clinical audience as Drip Infusion but restricts its scope to gravity-fed intravenous therapy.
The Analyst's Read
The bottom line on iLeaf
Bottom line
iLeaf is a niche utility developer that succeeds when leveraging native iOS capabilities for specific user needs. Their long-term viability depends on whether they can sustain the recent development momentum across their entire portfolio rather than relying on a single flagship title.
Frequently asked questions
How many apps does iLeaf publish?
What kind of apps does iLeaf make?
What is iLeaf's top app?
In how many countries are iLeaf's apps available?
What fed this analysis
- Apps analyzed:
- 6
- With full intel:
- 0
- With overview:
- 6
- Website scraped:
- yes
- Social presence:
- no